InvestorsHub Logo
Followers 129
Posts 3809
Boards Moderated 0
Alias Born 07/12/2003

Re: None

Wednesday, 09/06/2023 2:06:01 PM

Wednesday, September 06, 2023 2:06:01 PM

Post# of 198629
If ENZC get the Business Combination Agreement signed, sealed and delivered then we can look forward to the following:

1. ITV-1 immunotherapy treatment in Africa

2. ITV-1 clinical trials in Bulgaria

3. Partnership with Khalpey AI Lab (https://khalpey-ai.com ) and Contenta, Ltd.

4. The issuance of multiple international patents

5.Collaborate with pharma entities and license its technology or partner with major pharma entities now producing therapies for COVID-19.

6.Clone 3

Regarding the Company's therapeutic against HIV, the Company has produced a fully human anti-HIV monoclonal Antibody, Clone 3. The Company is now producing additional anti-HIV mAbs to be used in combination. Experts agree that a cure for HIV may be found in the production and administration of multiple anti-HIV monoclonal antibodies. This is the Company's goal. The Company has successfully produced and tested, in vitro, one HIV monoclonal antibody (Clone 3) and has identified 7 additional immutable conserved sites on the HIV virus against which it is in the process of producing anti-monoclonal antibodies. These antibodies will be produced as fully human, with the starting point being human "immune-B cells" from long-term non-progressor HIV patients. This production is being conducted with pharmaceutical entities to accelerate the process of production and testing of the monoclonal antibodies.



The Company's near-term objective is collaboration with pharma companies producing treatments for HIV. The current HIV treatments available do not cure and must be taken for a lifetime. The Company is focused on licensing or partnering with major pharma entities now producing treatments for HIV. To accelerate and fully execute the successful production of the multiple monoclonal antibodies, the subject of the Company's intellectual property, the Company continuously engages with multiple pharma entities to accomplish the successful goal of production, testing, and delivery of successful therapeutics.



7. Patent disputes

ENZC has a lot going on and management has been very upbeat, confident and excited about the Business Combination Agreement.

The question is "Can ENZC deliver the Goods" and bring home the bacon.

This would be their biggest accomplishment yet.

After years of promises, milestones gone awry (and still continues to) will ENZC finally finish the deal.

After years of upbeat, colorful, promise filled, projections, collaborations, NDAs, patents this an patent that messaging from ENZC, I just have one Question.

Do you really want me to tell you how I feel?

I feel Good

I feel Shitty

I feel ENZC gonna make me Giddy

I feel Mad

I feel sad

I feel ENZC gonna make me Glad

I feel lost

I feel crossed

I feel ENZC gonna make me crossed


ENZC is like a movie with a lot of moving parts and very hard to follow.